In my inbox at work today from Pfizer Australia:Did you know...

In my inbox at work today from Pfizer Australia:

Did you know that COVID-19 is one of Australia's leading cause of death?3

The Australian Bureau of Statistics (ABS) highlighted that COVID-19 was the third-leading cause of death in 2022, with one-in-three of those who died also having a pre-existing cardiac condition.3 In 2020–21, more than 11 million Australian adults reported living with a chronic condition like cardiovascular disease, diabetes, kidney disease or asthma,4 putting them at increased risk of severe COVID-19. When it comes to COVID-19, any of the following factors can make it more likely that a person will progress to severe illness:1,5

PAXLOVID is recommended as the first line oral antiviral treatment option for COVID-19 in high-risk, adult patients at risk of hospitalisation or death and treatment can be initiated within 5 days of symptom onset 2,6,7 SARS-CoV-2 replicates rapidly, and even mild COVID-19 can quickly become severe for those with risk factors.8-10 Don’t wait for worsening symptoms. Initiate PAXLOVID early – within 5 days of symptom onset – to reduce the risk of progression to severe disease in your high-risk patients.1

PAXLOVID can help reduce the risk of severe disease in your elderly patients1,11

Significantly reduces the risk of COVID-19-related hospitalisation or death by 88%1,11* *When taken within 5 days of symptom onset. Efficacy compared with placebo through Day 28 in the EPIC-HR clinical trial (P<0.001; secondary endpoint; data collected up to December 2021)11

Multiple real-world studies support the efficacy of PAXLOVID in Omicron variants† and vaccinated patients12–17 †variants include BA.1, BA.2, BA.4 and BA.5

Similar rates of adverse events vs placebo1,11‡ ‡Incidence of treatment emergent adverse events were similar between PAXLOVID (22.6%) and placebo (23.9%), and mostly mild or moderate1,11

Don’t wait for worsening symptoms. Act fast to treat COVID within 5 days of symptom onset.1

Find out more about prescribing PAXLOVID to your elderly patients with COVID-19

Paxlovid Patient Resources in six different languages including English, Traditional & Simplified Chinese, Arabic, Italian and Greek DOWNLOAD